NO20010619D0 - Krystallin base av citalopram - Google Patents

Krystallin base av citalopram

Info

Publication number
NO20010619D0
NO20010619D0 NO20010619A NO20010619A NO20010619D0 NO 20010619 D0 NO20010619 D0 NO 20010619D0 NO 20010619 A NO20010619 A NO 20010619A NO 20010619 A NO20010619 A NO 20010619A NO 20010619 D0 NO20010619 D0 NO 20010619D0
Authority
NO
Norway
Prior art keywords
citalopram
crystalline base
crystalline
base
Prior art date
Application number
NO20010619A
Other languages
English (en)
Other versions
NO20010619L (no
NO312031B1 (no
Inventor
Hans Petersen
Klaus Peter Boegesoe
Per Holm
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8159320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20010619(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20010619D0 publication Critical patent/NO20010619D0/no
Publication of NO20010619L publication Critical patent/NO20010619L/no
Publication of NO312031B1 publication Critical patent/NO312031B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Laminated Bodies (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20010619A 2000-03-13 2001-02-06 Krystallin base av citalopram NO312031B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200000402 2000-03-13
DKPCT/DK00/00183 2000-04-13

Publications (3)

Publication Number Publication Date
NO20010619D0 true NO20010619D0 (no) 2001-02-06
NO20010619L NO20010619L (no) 2001-09-14
NO312031B1 NO312031B1 (no) 2002-03-04

Family

ID=8159320

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20010619A NO312031B1 (no) 2000-03-13 2001-02-06 Krystallin base av citalopram
NO20020356A NO315851B1 (no) 2000-03-13 2002-01-23 Krystallinsk base av citalopram

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20020356A NO315851B1 (no) 2000-03-13 2002-01-23 Krystallinsk base av citalopram

Country Status (42)

Country Link
US (7) US20010031784A1 (no)
EP (2) EP1169314B2 (no)
JP (1) JP2003527383A (no)
KR (1) KR20020080486A (no)
CN (2) CN1680350A (no)
AR (1) AR029811A1 (no)
AT (3) ATE223396T1 (no)
AU (2) AU746664B2 (no)
BE (1) BE1013210A3 (no)
BG (1) BG107065A (no)
BR (1) BR0109373A (no)
CA (2) CA2411732A1 (no)
CH (2) CH691537A5 (no)
CZ (1) CZ292077B6 (no)
DE (7) DE20007303U1 (no)
DK (3) DK173903B1 (no)
EA (1) EA200200972A1 (no)
ES (3) ES2173054T3 (no)
FI (2) FI20010156A0 (no)
FR (1) FR2806086B1 (no)
GB (2) GB2357762B (no)
GR (1) GR1003796B (no)
HK (1) HK1054750A1 (no)
HR (1) HRP20020756A2 (no)
HU (3) HU0001581D0 (no)
IE (1) IES20010109A2 (no)
IL (2) IL158072A0 (no)
IS (1) IS5841A (no)
IT (2) IT1319645B1 (no)
MX (1) MXPA02008793A (no)
NL (2) NL1016435C1 (no)
NO (2) NO312031B1 (no)
PL (1) PL360158A1 (no)
PT (2) PT1227088E (no)
SE (2) SE517136C2 (no)
SI (2) SI1227088T1 (no)
SK (1) SK285528B6 (no)
TR (1) TR200202185T2 (no)
UA (1) UA74360C2 (no)
WO (1) WO2001068627A1 (no)
YU (1) YU68802A (no)
ZA (1) ZA200207148B (no)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9917346A (pt) * 1999-04-14 2002-02-26 Lundbeck & Co As H Método para preparação de citalopram intermadiário e utilização do mesmo
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
US6299622B1 (en) 1999-08-19 2001-10-09 Fox Hollow Technologies, Inc. Atherectomy catheter with aligned imager
US7708749B2 (en) 2000-12-20 2010-05-04 Fox Hollow Technologies, Inc. Debulking catheters and methods
US7713279B2 (en) 2000-12-20 2010-05-11 Fox Hollow Technologies, Inc. Method and devices for cutting tissue
US7887556B2 (en) 2000-12-20 2011-02-15 Fox Hollow Technologies, Inc. Debulking catheters and methods
US8328829B2 (en) 1999-08-19 2012-12-11 Covidien Lp High capacity debulking catheter with razor edge cutting window
IES20010157A2 (en) 2000-03-03 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
NL1017500C1 (nl) 2000-03-13 2001-04-26 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
GB2376233B (en) * 2000-08-10 2003-09-10 Lundbeck & Co As H Crystals of a pharmaceutically acceptable salt of citalopram wherein the median size of the crystals is at least 40 microns
IS6021A (is) * 2000-08-10 2001-10-20 H. Lundbeck A/S Lyfjasamsetningar sem innihalda sítalópram
WO2002049690A2 (en) 2000-12-20 2002-06-27 Fox Hollow Technologies, Inc. Debulking catheter
ATE277920T1 (de) * 2000-12-22 2004-10-15 Lundbeck & Co As H Verfahren zur vorbereitung von reinem citalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0105627D0 (en) * 2001-03-07 2001-04-25 Cipla Ltd Preparation of phthalanes
MXPA03008777A (es) * 2001-05-01 2004-02-12 Lundbeck & Co As H El uso de escitalopram enantiomericamente puro.
ATE286730T1 (de) 2001-07-31 2005-01-15 Lundbeck & Co As H Kristalline zusammensetzung mit escitalopram
AU2003222435A1 (en) * 2002-01-07 2003-07-24 Sun Pharmaceutical Industries Limited Process for the preparation of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
GB0204607D0 (en) * 2002-02-27 2002-04-10 Matrix Lab Ltd Process
GB2386119A (en) * 2002-02-27 2003-09-10 Cipla Ltd Purification of citalopram
GB2387844B (en) * 2002-02-27 2005-05-11 Matrix Lab Ltd Separation of impurities from a crude mixture of citalopram
GB2385848A (en) * 2002-02-27 2003-09-03 Cipla Ltd Citalopram salts
GB2386118A (en) * 2002-02-27 2003-09-10 Cipla Ltd Citalopram
EP1346989A1 (en) * 2002-03-21 2003-09-24 Jubilant Organosys Limited Improved process for the preparation of citalopram and its hydrobromide
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
AU2003223105A1 (en) * 2003-03-24 2004-10-18 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
WO2004094399A1 (en) * 2003-04-21 2004-11-04 Natco Pharma Ltd An improved process for the preparation of citalopram hydrobromide
US8246640B2 (en) 2003-04-22 2012-08-21 Tyco Healthcare Group Lp Methods and devices for cutting tissue at a vascular location
EP1486492A3 (en) * 2003-06-10 2005-02-23 Sun Pharmaceuticals Industries Ltd. A process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran.
GB0317475D0 (en) 2003-07-25 2003-08-27 Meditab Specialities Pvt Ltd Product
JP4025735B2 (ja) * 2003-08-21 2007-12-26 ローム アンド ハース カンパニー 水性系を処理する方法
GB0320312D0 (en) 2003-08-29 2003-10-01 Novartis Ag Purification process
CN100569765C (zh) * 2003-12-19 2009-12-16 杭州民生药业集团有限公司 西酞普兰中间体晶体碱
ITTO20050301A1 (it) * 2005-05-05 2006-11-06 Errekappa Euroterapici Spa Formulazioni liquide orali contenenti citalopram
US20110196032A1 (en) * 2005-05-20 2011-08-11 Ashish Gogia Pharmaceutical Dosage Form of an Antidepressant
TWI347942B (en) * 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
JP5095615B2 (ja) 2005-06-27 2012-12-12 バリアント・インターナショナル・（バルバドス）・ソサイアティーズ・ウィズ・リストリクティッド・ライアビリティ ブプロピオン塩の放出調整製剤
US20070276419A1 (en) 2006-05-26 2007-11-29 Fox Hollow Technologies, Inc. Methods and devices for rotating an active element and an energy emitter on a catheter
US8784440B2 (en) 2008-02-25 2014-07-22 Covidien Lp Methods and devices for cutting tissue
US8414604B2 (en) 2008-10-13 2013-04-09 Covidien Lp Devices and methods for manipulating a catheter shaft
WO2010126882A1 (en) 2009-04-29 2010-11-04 Fox Hollow Technologies, Inc. Methods and devices for cutting and abrading tissue
CA2761774C (en) 2009-05-14 2014-09-16 Tyco Healthcare Group Lp Easily cleaned atherectomy catheters and methods of use
CN102695462B (zh) 2009-12-02 2015-01-14 泰科保健集团有限合伙公司 用于切割组织的方法和装置
US20110144673A1 (en) 2009-12-11 2011-06-16 Fox Hollow Technologies, Inc. Material removal device having improved material capture efficiency and methods of use
ES2482608T3 (es) 2010-06-14 2014-08-04 Covidien Lp Dispositivo de retirada de material
JP5636114B2 (ja) 2010-10-28 2014-12-03 コヴィディエン リミテッド パートナーシップ 物質除去デバイスおよび使用方法
KR20150020240A (ko) 2010-11-11 2015-02-25 코비디엔 엘피 촬영용 가요성 디벌킹 카테터와, 사용 및 제조 방법
US8992717B2 (en) 2011-09-01 2015-03-31 Covidien Lp Catheter with helical drive shaft and methods of manufacture
US9532844B2 (en) 2012-09-13 2017-01-03 Covidien Lp Cleaning device for medical instrument and method of use
US9943329B2 (en) 2012-11-08 2018-04-17 Covidien Lp Tissue-removing catheter with rotatable cutter
WO2015200702A1 (en) 2014-06-27 2015-12-30 Covidien Lp Cleaning device for catheter and catheter including the same
US10314667B2 (en) 2015-03-25 2019-06-11 Covidien Lp Cleaning device for cleaning medical instrument
US10292721B2 (en) 2015-07-20 2019-05-21 Covidien Lp Tissue-removing catheter including movable distal tip
US10314664B2 (en) 2015-10-07 2019-06-11 Covidien Lp Tissue-removing catheter and tissue-removing element with depth stop
WO2021016112A2 (en) 2019-07-19 2021-01-28 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2233970A (en) * 1941-03-04 Quinoline compound and process of
US2584429A (en) * 1950-12-29 1952-02-05 Rohm & Haas 1,1-diphenyl-4-tert.-amino-2-butyne-1-ols
GB1143703A (no) * 1965-03-18
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
DK213290D0 (da) 1990-09-06 1990-09-06 Lundbeck & Co As H Treatment of cerebrovascular disorders
CA2120874E (en) * 1994-04-08 2002-01-08 Keshava Murthy Form of form 1 ranitidine
EA001728B1 (ru) * 1997-07-08 2001-08-27 Х.Лундбекк А/С Способ получения циталопрама
UA62985C2 (en) * 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
ES2149734T3 (es) * 1997-11-11 2003-02-16 Lundbeck & Co As H Metodo para la preparacion de citalopram.
NZ510858A (en) * 1998-10-20 2003-11-28 H Method for the preparation of citalopram
BR9917346A (pt) 1999-04-14 2002-02-26 Lundbeck & Co As H Método para preparação de citalopram intermadiário e utilização do mesmo
ITMI991579A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
US6433196B1 (en) * 2000-02-17 2002-08-13 Sumika Fine Chemicals Co., Ltd. Production method of citalopram, intermediate therefor and production method of the intermediate
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof

Also Published As

Publication number Publication date
CZ292077B6 (cs) 2003-07-16
KR20020080486A (ko) 2002-10-23
SE0103046L (sv) 2001-11-14
PL360158A1 (en) 2004-09-06
US20040167210A1 (en) 2004-08-26
IES20010109A2 (en) 2002-02-20
HU0100450D0 (en) 2001-04-28
DE10164687B4 (de) 2006-04-27
PT1227088E (pt) 2003-12-31
EA200200972A1 (ru) 2003-02-27
SE0103046D0 (sv) 2001-09-14
DK1227088T3 (da) 2003-12-22
US20050165244A1 (en) 2005-07-28
ATE250050T1 (de) 2003-10-15
SI1227088T1 (en) 2003-12-31
GB0102797D0 (en) 2001-03-21
BE1013210A3 (fr) 2001-10-02
DK1169314T3 (da) 2002-10-14
CZ2001808A3 (cs) 2002-01-16
EP1227088B1 (en) 2003-09-17
DE60100022T2 (de) 2003-03-06
ES2173054T3 (es) 2002-12-16
HU0100531D0 (en) 2001-03-28
ES2180471T3 (es) 2004-05-01
NO20010619L (no) 2001-09-14
AU3725201A (en) 2001-09-13
IL147339A0 (en) 2002-08-14
YU68802A (sh) 2005-11-28
DE60100022T3 (de) 2011-11-17
HRP20020756A2 (en) 2004-12-31
DE60100786T2 (de) 2004-07-15
US20010031784A1 (en) 2001-10-18
DE10108042A1 (de) 2001-10-18
DK173903B1 (da) 2002-02-11
FI109022B (fi) 2002-05-15
DE60100786D1 (de) 2003-10-23
SK13132002A3 (sk) 2003-01-09
DE60100022D1 (de) 2002-10-10
DE20007303U1 (de) 2000-07-27
SE517136C2 (sv) 2002-04-16
US20030078442A1 (en) 2003-04-24
HU0001581D0 (en) 2000-06-28
SI1169314T1 (en) 2002-12-31
GB0105982D0 (en) 2001-05-02
SI1169314T2 (sl) 2011-08-31
GR1003796B (el) 2002-02-08
SK285528B6 (sk) 2007-03-01
CH691537A5 (de) 2001-08-15
ES2173054T1 (es) 2002-10-16
CH691477A5 (de) 2001-07-31
EP1169314A1 (en) 2002-01-09
HK1054750A1 (en) 2003-12-12
FR2806086A1 (fr) 2001-09-14
JP2003527383A (ja) 2003-09-16
ITMI20010406A1 (it) 2002-08-28
SE0200730L (sv) 2002-08-29
PT1169314E (pt) 2002-11-29
GB2357762A (en) 2001-07-04
CA2411732A1 (en) 2001-09-20
GB2357762B (en) 2002-01-30
CN1429220A (zh) 2003-07-09
SE0200730D0 (sv) 2002-03-12
CN1258530C (zh) 2006-06-07
US20060247451A1 (en) 2006-11-02
ITMI20002425A1 (it) 2002-05-09
NL1016435C1 (nl) 2000-11-06
NO20020356D0 (no) 2002-01-23
FI20010225A (fi) 2001-09-14
ES2159491A1 (es) 2001-10-01
UA74360C2 (uk) 2005-12-15
US20050165092A1 (en) 2005-07-28
ATE223396T1 (de) 2002-09-15
IS5841A (is) 2001-09-14
IL147339A (en) 2004-09-27
AU746664B2 (en) 2002-05-02
ZA200207148B (en) 2003-04-23
FI20010225A0 (fi) 2001-02-07
EP1169314B2 (en) 2011-06-01
ES2180471T1 (es) 2003-02-16
IT1319645B1 (it) 2003-10-23
CA2360287A1 (en) 2001-09-20
AT4364U1 (de) 2001-06-25
TR200202185T2 (tr) 2002-12-23
BR0109373A (pt) 2002-12-24
NO312031B1 (no) 2002-03-04
NL1017413C1 (nl) 2001-09-13
ES2159491B1 (es) 2002-05-01
AR029811A1 (es) 2003-07-16
EP1227088A1 (en) 2002-07-31
MXPA02008793A (es) 2003-02-12
BG107065A (bg) 2003-05-30
FI20010156A0 (fi) 2001-01-25
IL158072A0 (en) 2004-03-28
HUP0100531A3 (en) 2004-04-28
NO20020356L (no) 2001-09-14
EP1169314B1 (en) 2002-09-04
NO315851B1 (no) 2003-11-03
WO2001068627A1 (en) 2001-09-20
CA2360287C (en) 2003-09-09
CN1680350A (zh) 2005-10-12
DE20121240U1 (de) 2002-07-04
AU2001100197A4 (en) 2001-09-20
AU2001100197B4 (en) 2001-12-06
HUP0100531A2 (hu) 2002-01-28
SE526022C2 (sv) 2005-06-14
FR2806086B1 (fr) 2003-05-09
DE1227088T1 (de) 2003-02-06
US20040132808A1 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
NO20010619L (no) Krystallin base av citalopram
FI20011578A0 (fi) Menetelmä puhtaan sitalopraamin valmistamiseksi
NO20013942D0 (no) Fremgangsmate for fremstilling av Citalopram
NO20023072L (no) Syntese av krystallinske silikoaluminofosfater
NO20024527D0 (no) Krystallinsk form II av kabergolin
NO20013891D0 (no) Sammensetninger omfattende citalopram
NO20025423D0 (no) FremgangsmÕte for fremstilling av Citalopram
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
NO20021118D0 (no) Fremgangsmåte for fremstilling av citalopram
FI20001451A (fi) Lasintyöstöterien kunnostus
SE9902239D0 (sv) Kornisch bestående av flera delar
UA4579S (uk) Дозиметр-радіометр гамма-бета-випромінювань

Legal Events

Date Code Title Description
CB Opposition filed (par. 26,5 patents act)

Opponent name: BIOCHEMIE GMBH, A-6250 KUNDL, AT

Effective date: 20021129

Opponent name: RATIOPHARM GMBH, D-89070 ULM, DE

Effective date: 20021203